{"component": "definition", "props": {"groups": [{"snippet": "means any oncological disease or condition. For clarity, a distinct form of cancer (e.g., breast cancer) shall be considered a separate Tumor Type from other distinct forms of cancer (e.g., ovarian cancer), provided that, distinct patient populations within a disease or condition shall not be considered separate Tumor Types. For the avoidance of doubt, the treatment of the same Tumor Type in a different patient population, or as a different line of therapy, shall not be deemed to be a separate Tumor Type for purposes of this Agreement.", "size": 5, "samples": [{"hash": "jpnZcbP2zYu", "uri": "/contracts/jpnZcbP2zYu#tumor-type", "label": "Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)", "score": 31.8446269678, "published": true}, {"hash": "ggnshgntmlA", "uri": "/contracts/ggnshgntmlA#tumor-type", "label": "Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)", "score": 26.749486653, "published": true}, {"hash": "lgwM84kDb46", "uri": "/contracts/lgwM84kDb46#tumor-type", "label": "Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)", "score": 26.7385352498, "published": true}], "snippet_links": [{"key": "for-clarity", "type": "clause", "offset": [44, 55]}, {"key": "form-of", "type": "definition", "offset": [68, 75]}, {"key": "breast-cancer", "type": "clause", "offset": [90, 103]}, {"key": "a-separate", "type": "definition", "offset": [125, 135]}, {"key": "ovarian-cancer", "type": "definition", "offset": [190, 204]}, {"key": "provided-that", "type": "clause", "offset": [207, 220]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [327, 353]}, {"key": "treatment-of", "type": "definition", "offset": [359, 371]}, {"key": "patient-population", "type": "clause", "offset": [407, 425]}, {"key": "line-of", "type": "definition", "offset": [445, 452]}, {"key": "for-purposes-of-this-agreement", "type": "definition", "offset": [510, 540]}], "hash": "7795a798073bb57f99406d9133065f63", "id": 1}, {"snippet": "means each of the following separate tumor disease areas: (i) breast cancer; (ii) NSCLC; (iii) colorectal cancer; (iv) non-Hodgkin\u2019s lymphoma; (v) prostate cancer; (vi) gastric cancer; and (vii) ovarian cancer.", "size": 3, "samples": [{"hash": "fdqNlV4D1JZ", "uri": "/contracts/fdqNlV4D1JZ#tumor-type", "label": "License Agreement (Coley Pharmaceutical Group, Inc.)", "score": 21.0, "published": true}, {"hash": "cPywL9CJcG8", "uri": "/contracts/cPywL9CJcG8#tumor-type", "label": "License Agreement (Coley Pharmaceutical Group, Inc.)", "score": 21.0, "published": true}, {"hash": "856bUba9bby", "uri": "/contracts/856bUba9bby#tumor-type", "label": "License Agreement (Coley Pharmaceutical Group, Inc.)", "score": 21.0, "published": true}], "snippet_links": [{"key": "breast-cancer", "type": "clause", "offset": [62, 75]}, {"key": "colorectal-cancer", "type": "clause", "offset": [95, 112]}, {"key": "prostate-cancer", "type": "clause", "offset": [147, 162]}, {"key": "ovarian-cancer", "type": "definition", "offset": [195, 209]}], "hash": "333536977dee43386116cac37dedbe3f", "id": 2}, {"snippet": "means a particular oncologic malignancy based on the organ or tissue in which the malignancy originates. A breast Tumor Type will be a different Tumor Type from a pancreatic Tumor Type, but a HER2+ breast Tumor Type will be the same Tumor Type as a BRCA1 breast Tumor Type.", "size": 3, "samples": [{"hash": "4emG2aj9DwU", "uri": "/contracts/4emG2aj9DwU#tumor-type", "label": "License Agreement (Pyxis Oncology, Inc.)", "score": 33.8323066393, "published": true}, {"hash": "2VJpeKJhJsN", "uri": "/contracts/2VJpeKJhJsN#tumor-type", "label": "License Agreement (Pyxis Oncology, Inc.)", "score": 32.7097878166, "published": true}, {"hash": "kRnF2zT4UhG", "uri": "https://ir.pyxisoncology.com/static-files/78431333-5d77-4506-a28c-eed7047d3d9a", "label": "ir.pyxisoncology.com", "score": 11.6461327858, "published": false}], "snippet_links": [{"key": "based-on", "type": "clause", "offset": [40, 48]}], "hash": "496e3e46c1ea9b62d4c81b0812006845", "id": 3}, {"snippet": "means any histologically distinct cancer with a particular organ of origin, which histology and organ of origin shall be determined in accordance with the Clinical Practice Guidelines in Oncology of the National Comprehensive Cancer Network. Tumor Types will be deemed the same for purposes of this Agreement if the subject cancers have the same organ of origin even if they are, for example, of a different disease stage or different line of therapy (e.g., well-differentiated and poorly differentiated gastric cancer, 1st line NSCLC and 2nd line NSCLC), and will be deemed different if the subject cancers have different organs of origin (e.g., gastric cancer and lung cancer) or different histology (e.g., NSCLC and SCLC). Among non-solid tumor cancers, Tumor Types for leukemia, lymphoma and multiple myeloma, but not their subtypes or lines of therapy, shall be considered different Tumor Types.", "size": 2, "samples": [{"hash": "BAUrzSRPL7", "uri": "/contracts/BAUrzSRPL7#tumor-type", "label": "Clinical Trial Collaboration Agreement (Five Prime Therapeutics Inc)", "score": 26.2073921971, "published": true}, {"hash": "eUg0TmBbFdr", "uri": "http://investor.fiveprime.com/static-files/1f56c0ae-267a-46b9-95c7-3e52e146583f", "label": "investor.fiveprime.com", "score": 10.1704312115, "published": false}], "snippet_links": [{"key": "in-accordance-with", "type": "definition", "offset": [132, 150]}, {"key": "clinical-practice-guidelines", "type": "definition", "offset": [155, 183]}, {"key": "the-national", "type": "clause", "offset": [199, 211]}, {"key": "for-purposes-of-this-agreement", "type": "definition", "offset": [278, 308]}, {"key": "the-subject", "type": "clause", "offset": [312, 323]}, {"key": "for-example", "type": "clause", "offset": [380, 391]}, {"key": "line-of", "type": "definition", "offset": [435, 442]}, {"key": "lung-cancer", "type": "definition", "offset": [666, 677]}], "hash": "ec0dba6728fe03ebb256e10f72c553b9", "id": 4}, {"snippet": "means a cancer that differs from another type of cancer in [***].\n1. 129 \u201cUnited States\u201d or \u201cU.S.\u201d means the United States of America, including its territories and possessions.", "size": 2, "samples": [{"hash": "jwubpaXYIcP", "uri": "/contracts/jwubpaXYIcP#tumor-type", "label": "Collaborative Research, Development and Commercialization Agreement (Revolution Medicines, Inc.)", "score": 31.0424366872, "published": true}, {"hash": "b3Fa171OBsz", "uri": "/contracts/b3Fa171OBsz#tumor-type", "label": "Collaborative Research, Development and Commercialization Agreement (Revolution Medicines, Inc.)", "score": 30.7138945927, "published": true}], "snippet_links": [{"key": "type-of", "type": "definition", "offset": [41, 48]}, {"key": "the-united-states-of-america", "type": "clause", "offset": [105, 133]}], "hash": "a6ded14668c0f816d2bdbeaf6f1c8ecc", "id": 5}, {"snippet": "means a primary neoplastic disease, including any metastasis thereof, as accepted in standard medical practice.", "size": 2, "samples": [{"hash": "lS9X0QHLuvL", "uri": "/contracts/lS9X0QHLuvL#tumor-type", "label": "Database / Vaccine Collaboration Project Agreement (Immatics N.V.)", "score": 35.2176591376, "published": true}], "snippet_links": [{"key": "standard-medical-practice", "type": "definition", "offset": [85, 110]}], "hash": "309f425b6c23ce7715ee3698a805e104", "id": 6}, {"snippet": "Tumor Type shall mean any type or form of Hematological Cancer, Solid Tumor Cancer or other cancer, including CLL, DLBCL, FL, MCL and MM.", "size": 1, "samples": [{"hash": "lXz1DJQQJ1e", "uri": "/contracts/lXz1DJQQJ1e#tumor-type", "label": "Collaboration and License Agreement (Pharmacyclics Inc)", "score": 23.1054072553, "published": true}], "snippet_links": [{"key": "form-of", "type": "definition", "offset": [34, 41]}], "hash": "85f8d4887ef293b56868112fcf3feafe", "id": 7}, {"snippet": "as opposed to another Tumor Type, shall be [[***]].", "size": 1, "samples": [{"hash": "4GESAH7jTph", "uri": "/contracts/4GESAH7jTph#tumor-type", "label": "Research and Development and License Agreement (Atara Biotherapeutics, Inc.)", "score": 32.1622176591, "published": true}], "snippet_links": [], "hash": "26a10ac9e6365af3230f594bc8645b70", "id": 8}, {"snippet": "is defined in Section 7.2.3.", "size": 1, "samples": [{"hash": "4vuGUY8yxMp", "uri": "/contracts/4vuGUY8yxMp#tumor-type", "label": "Research Collaboration and License Agreement (Five Prime Therapeutics Inc)", "score": 26.8425735797, "published": true}], "snippet_links": [{"key": "section-723", "type": "clause", "offset": [14, 27]}], "hash": "11c725c96ceb94101c42ed872a3fab12", "id": 9}, {"snippet": "means a type of cancer that differs from another type of cancer with respect to the histology and origin of the tumor, including Breast Cancer Tumor Type, [**], Gastric Cancer Tumor Type, Lung Cancer Tumor Type and [**].", "size": 1, "samples": [{"hash": "e0E2g8YOEV1", "uri": "/contracts/e0E2g8YOEV1#tumor-type", "label": "Collaboration, Option and License Agreement (Mersana Therapeutics, Inc.)", "score": 31.848733744, "published": true}], "snippet_links": [{"key": "type-of", "type": "definition", "offset": [8, 15]}, {"key": "with-respect-to", "type": "clause", "offset": [64, 79]}, {"key": "origin-of", "type": "definition", "offset": [98, 107]}, {"key": "breast-cancer", "type": "clause", "offset": [129, 142]}, {"key": "lung-cancer", "type": "definition", "offset": [188, 199]}], "hash": "c68a41e6e9d06b2396f61b059aa86870", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiITdHVtb3ItdHlwZSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means any oncological disease or condition. For clarity, a distinct form of cancer (e.g., breast cancer) shall be considered a separate Tumor Type from other distinct forms of cancer (e.g., ovarian cancer), provided that, distinct patient populations within a disease or condition shall not be considered separate Tumor Types. For the avoidance of doubt, the treatment of the same Tumor Type in a different patient population, or as a different line of therapy, shall not be deemed to be a separate Tumor Type for purposes of this Agreement.", "size": 21, "title": "Tumor Type", "id": "tumor-type", "examples": ["Subject to Pfizer exercising an Option pursuant to Section 4.1.2, on a Research Project Target-by-Research Project Target basis, Pfizer will use Commercially Reasonable Efforts to Commercialize one (1) Licensed Product in one (1) Major Market Country in the Field for one (1) <strong>Tumor Type</strong> where Pfizer has received Regulatory Approval for such Licensed Product in such country.", "For clarity, a distinct form of cancer (e.g., breast cancer) shall be considered a separate <strong>Tumor Type</strong> from other distinct forms of cancer (e.g., ovarian cancer), provided that, distinct patient populations within a disease or condition shall not be considered separate <strong>Tumor Types</strong>.", "For the avoidance of doubt, the treatment of the same <strong>Tumor Type</strong> in a different patient population, or as a different line of therapy, shall not be deemed to be a separate <strong>Tumor Type</strong> for purposes of this Agreement.", "Notwithstanding the foregoing, in the event of any such uncured material breach affecting only a particular Collaboration <strong>Tumor Type</strong> or Collaboration Compounds or Products directed to such Collaboration <strong>Tumor Type</strong> (collectively, a \u201cCollaboration Program\u201d), such termination shall apply only to the affected Collaboration Program, and this Agreement shall otherwise remain in full force and effect.", "In the event that the JDC determines to add the GTT Proposed Study to the GDP, the applicable <strong>tumor type</strong> shall remain a Genentech <strong>Tumor Type</strong> and the applicable Indication shall become a GDP Indication.", "On a Licensed Collaboration <strong>Tumor Type</strong>-by-Licensed Collaboration <strong>Tumor Type</strong> basis, Providence (directly or through its Affiliates or Sublicensees) shall use Commercially Reasonable Efforts to Develop, obtain Regulatory Approval for, and Commercialize at least one Product for each Licensed Collaboration <strong>Tumor Type</strong> in the Licensed Field in each of the Major Markets.", "For clarity, any inference or reference to a \u201cfirst, \u201csecond\u201d or \u201cthird\u201d <strong>Tumor Type</strong> above, shall be construed to mean the \u201cfirst\u201d, \u201csecond\u201d or \u201cthird\u201d <strong>Tumor Type</strong> that achieves the applicable milestone event, regardless of how many other <strong>Tumor Types</strong> have been previously pursued with respect to the same or other Licensed Products without achieving the applicable milestone event; this means, [[***]].", "As promptly as practicable Arcturus shall make available to Providence all Arcturus Know-How that is available in written, graphic, electronic or other recorded form (or true and complete copies thereof), that is reasonably necessary or useful for Providence to exercise its rights and perform its obligations under this Agreement with respect to Collaboration Compounds for such Collaboration <strong>Tumor Type</strong> and Products containing such Collaboration Compounds.", "In such case, upon BioNTech\u2019s timely (within the [***] timeframe described in the preceding sentence) Initiation of the GTT Proposed Study and so long as BioNTech is using Commercially Reasonable Efforts to Conduct such GTT Proposed Study, the GTT Proposed Study will be a BioNTech Study, the proposed Indication will be a BioNTech Indication and the applicable <strong>tumor type</strong> will cease to be a Genentech <strong>Tumor Type</strong>.", "On a Collaboration <strong>Tumor Type</strong>-by-Collaboration <strong>Tumor Type</strong> basis, Arcturus shall use Commercially Reasonable Efforts to perform the Research Program for each Collaboration <strong>Tumor Type</strong> in an expeditious manner."], "related": [["prop-type", "Prop Type", "Prop Type"], ["engine-type", "engine type", "engine type"], ["license-type", "License Type", "License Type"], ["service-type", "Service Type", "Service Type"], ["product-type", "product type", "product type"]], "related_snippets": [], "updated": "2025-07-06T21:58:29+00:00"}, "json": true, "cursor": ""}}